2.50
price up icon6.38%   0.15
pre-market  Vorhandelsmarkt:  2.38   -0.12   -4.80%
loading

Finanzdaten der Inovio Pharmaceuticals Inc-Aktie (INO)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-06-30 2024-03-31 2023-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
100.00%
-
0.0653 0.1008 - 0.1027
Operating Expenses
8.09%
23.08
25.12 33.30 31.48 27.50
Benefits Costs and Expenses
-
- - - 25.11
Costs And Expenses
8.09%
23.08
25.12 33.30 31.48 25.11
Operating Income/Loss
7.85%
-23.08
-25.05 -33.20 -31.48 -27.39
Income/Loss From Continuing Operations Before Tax
19.42%
-23.52
-19.69 0.1008 -30.47 -25.00
Income/Loss From Continuing Operations After Tax
19.42%
-23.52
-19.69 -32.24 -30.47 -24.97
Net Income/Loss
19.42%
-23.52
-19.69 -32.24 -30.47 -25.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Diluted Average Shares
0.56%
38.83
38.61 27.20 23.29 -241.67
Basic Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Diluted Earnings Per Share
19.61%
-0.61
-0.51 -1.19 -1.31 -5.67
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$37.30
price down icon 0.64%
$28.71
price up icon 0.35%
$101.57
price up icon 8.65%
$103.95
price up icon 0.04%
biotechnology ONC
$311.86
price up icon 0.44%
$186.23
price down icon 1.78%
Kapitalisierung:     |  Volumen (24h):